Sleep disorders
Can't sleep? Your microbiome may play a role
Sleep is a hot commodity—we want it, we need it, but most of us aren't getting enough of it.
Nov 12, 2025
0
0
Sorted by popular
Immunology
How the gut builds long-lasting immunity after viral infections
A new study led by University of Toronto researchers has shown that immune cells in the gut follow an atypical pathway to produce antibodies that provide long-term protection against viruses.
21 hours ago
0
33
Neuroscience
Can brain training really shave ten years off brain aging, as a recent study suggests?
A ten-week online brain training program helped older adults' brains act as though they were a decade younger, a recent study has found.
Nov 11, 2025
0
0
Medical research
Scientific researchers urge Congress to increase funding to the NIH as the shutdown ends
The record-breaking federal government shutdown marked yet another impediment to scientific research efforts at the Wistar Institute this year.
Nov 15, 2025
0
0
Psychology & Psychiatry
Understudied eating disorder matches anorexia, bulimia severity
A diagnosis often viewed as less serious than anorexia and bulimia—and the most common eating disorder worldwide—can cause just as much harm, a new study has found.
Nov 12, 2025
0
1
Medications
FDA approves Caplyta for major depressive disorder in adults
The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults.
Nov 13, 2025
0
1
Autism spectrum disorders
Researchers develop new tool to study autism risk factors
University of Mississippi researchers have developed a new tool to help scientists study how environmental and genetic factors interact to influence autism spectrum disorder.
Nov 11, 2025
0
0
Diabetes
One-hour blood glucose level: A better chance to prevent diabetes
An elevated blood glucose level one hour after the oral glucose tolerance test (OGTT) signals a critical metabolic state—even before prediabetes. Affected individuals respond particularly well to lifestyle interventions. ...
Nov 12, 2025
0
0
Medications
FDA approves Darzalex Faspro for high-risk smoldering multiple myeloma
The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) as a single-agent treatment for adult patients with high-risk smoldering multiple myeloma (HR-SMM).
Nov 13, 2025
0
23
Health
Gun violence now a leading threat to pregnant women, study finds
Pregnant women in the United States face a serious and growing danger from gun violence, according to a new study that examined thousands of homicides nationwide.
Nov 14, 2025
0
0
